Roche proposes former Takeda CEO for board seat
23/09/2026 06:09
Roche proposes former Takeda CEO for board seat ZURICH, Sept 23 (Reuters) - Roche ROPC.S on Wednesday said it was proposing Christoph Weber, the former CEO of Takeda Pharmaceuticals 4502.T, for election to the Swiss company's board of directors at its AGM next March.
"Christophe's intimate knowledge of the healthcare industry and his broad leadership experience will further strengthen our Board," said Roche Chairman Severin Schwan in a statement.
(Reporting by John Revill
Editing by Linda Pasquini)((John.Revill@thomsonreuters.com; +41 41 528 36 37; Reuters Messaging: john.revill.thomsonreuters.com@reuters.net))
Recent news on Roche Holding AG
See all newsNovartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib
Brief: Roche Says Sefaxersen Achieved Statistically Significant 43.1% Reduction In Proteinuria In Interim Phase III Data
Brief: Zymeworks Signs Exclusive Global Licensing Deal With Roche For Cancer Drug ZW209
Zymeworks licenses experimental lung cancer drug to Roche in up to $813 million deal
DB ups Roche to 'buy' on positive oncology survey